Critical care in the emergency department: Severe sepsis and septic shock

Emergency Medicine Journal

Volumn 23, Issue 9, 2006, Pages 713-717

  Nee, Patrick A ^a  

^a WHISTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CEFUROXIME; DROTRECOGIN; GENTAMICIN; INSULIN; NORADRENALIN; OXYGEN; SODIUM CHLORIDE;

ABDOMINAL DISEASE; AGED; ANAMNESIS; ANTISEPSIS; ARTICLE; ARTIFICIAL VENTILATION; BACTERIUM ISOLATION; BLOOD CULTURE; BLOOD PRESSURE MONITORING; BREATHING RATE; CASE REPORT; CELLULITIS; CENTRAL VENOUS PRESSURE; CLINICAL FEATURE; DIABETIC KETOACIDOSIS; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; ELECTROCARDIOGRAM; EMERGENCY MEDICINE; EMERGENCY WARD; ENTERIC FEEDING; ENTEROCOCCUS; ERYTHEMA; FEMALE; FLUID THERAPY; GLASGOW COMA SCALE; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HEART RATE; HOSPITAL DISCHARGE; HUMAN; HYPOTENSION; INTENSIVE CARE; INTENSIVE CARE UNIT; KIDNEY FAILURE; LABORATORY TEST; LEG ULCER; LUNG DISEASE; NASOGASTRIC TUBE; OXIMETRY; OXYGEN THERAPY; PRIORITY JOURNAL; PUS; SEPSIS; SEPTIC SHOCK; STAPHYLOCOCCUS AUREUS; STROKE; THORAX RADIOGRAPHY; TRACHEOSTOMY; TREATMENT OUTCOME; URINE CATHETER; VEIN DISEASE; WOUND DRESSING;

AGED; ANTI-BACTERIAL AGENTS; CATHETERIZATION, CENTRAL VENOUS; CRITICAL CARE; EMERGENCY MEDICINE; FEMALE; GREAT BRITAIN; HUMANS; INCIDENCE; OXYGEN; PRACTICE GUIDELINES; SEPSIS; SHOCK, SEPTIC; SURVIVAL ANALYSIS; TREATMENT OUTCOME; UNITED STATES;

EID: 33748609114     PISSN: 14720205     EISSN: None     Source Type: Journal    
DOI: 10.1136/emj.2005.029934     Document Type: Article

References (32)

1. Angus DC, Linde-Zwirble WT, Lidecker J, et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome and associated costs of care. Crit Care Med 2001;29(7):1303-10.
2. Members of the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992;2:864-74.
3. Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003;31:1250-6.
4. Angus DC, Wax RS. Epidemiology of sepsis: an update. Crit Care Med 2001;29(7):S109-16.
5. Padkin A, Goldfrad C, Brady AR, et al. Epidemiology of severe sepsis occurring in the first 24 hours in intensive care units in England, Wales and Northern Ireland. Crit Care Med 2003;31(9):2332-8.
6. Jones GR. Assessment criteria in identifying the sick sepsis patient. J Infect 1998;37(suppl 1):24-9.
7. Dellinger RP, Carlet JM, Mansur H, et al. Surviving Sepsis Campaign guidelines for the management of severe sepsis and septic shock. Crit Care Med 2004;32(3):858-73.
8. Kellum JA, Angus DC. Genetic variation and risk of sepsis. Minerva Anestesiol 2003;69:245-53.
9. Gleckman R, Hibert D. Afebrile bacteremia: a phenomenon in geriatric patients. JAMA 1982;248:1478-81.
10. Fontanarosa P, Kaeberlein FJ, Gerson LW, et al. Difficulty in predicting bacteremia in elderly emergency patients. Ann Emerg Med 1992;21:841-8.
11. Shapiro NI, Wolfe RE, Moore RB, et al. Mortality in Emergency Department Sepsis (MEDS) score: a prospectively derived and validated clinical prediction rule. Crit Care Med 2003;31(3):968-9.
12. McCabe WR, Jackson GG. Gram-negative bacteremia. Arch Intern Med 1962;110:92-100.
13. Kreger BE, Craven DE, McCabe WR. Gram-negative bacteremia IV. Reevaluation of clinical features and treatment in 612 patients. Am J Med 1980;68:344-55.
14. Leibovici L, Shagra I, Drucker M. Ihe benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection. J Intern Med 1998;244:379-86.
15. Ibrahim EH, Sherman G, Ward S. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 2000;118:146-55.
16. Jones GR, Lowes JA. The systemic inflammatory response syndrome as a predictor of bacteraemia and outcome from sepsis. Q J Med 1996;89:515-22.
17. Choi PTL, Yip G, Quinonez LG. Crystalloids vs. colloids in fluid resuscitation: a systematic review, Crit Care Med 1999;27:200-10.
18. Cook D, Guyatt G. Colloid use for fluid resuscitation: evidence and spin. Ann Intern Med 2001;135:205-8.
19. Schierhout G, Roberts G. Fluid resuscitation with colloid or crystalloid solutions in critically ill patients. A systematic review of randomised trials. BMJ 1998;316(7136):961-4.
20. Brealey D, Singer M. Multi-organ dysfunction in the critically ill: epidemiology, pathophysiology and management. J R Coll Physicians Lond 2000;34:424-7.
21. Rivers EP, Nguyan B, Huang DT, et al. Early goal-directed therapy. Crit Care Med 2004;32(1):314-15.
22. Krafft P, Steltzer H, Hiesmayr M, et al. Mixed venous oxygen saturation in critically ill septic shock patients. The role of defined events. Chest 1993;103:900-6.
23. Edwards JD. Oxygen transport in cardiogenic and septic shock. Crit Care Med 1991;19:658-63.
24. Reinhart K, Rudolph T, Bredle DL, et al. Comparison of central venous to mixed venous oxygen saturation during changes in oxygen supply/demand. Chest 1989;95:1216-21.
25. Rady MY, Rivers EP, Nowak RM. Resuscitation of the critically ill in the ED: responses of blood pressure, heart rate, shock index, central venous oxygen saturation, and lactate. Am J Emerg Med 1996;14:218-25.
26. Rady MY, Rivers EP, Martin GB. Continuous central venous oximetry and shock index in the emergency department: use in the evaluation of clinical shock. Am J Emerg Med 1992;10:528-41.
27. Rivers EP, Nguyen HB, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001;345(19):1368-77.
28. Reinhart K, Kuhn HJ, Hartog C, et al. Continuous central venous and pulmonary artery oxygen saturation monitoring in the critically ill. Intensive Care Med 2004;30:1572-8.
29. Rivers EP, Ander DS, Powel D. Central venous oxygen saturation monitoring in the critically ill patient. Curr Opin Crit Care 2001;7:204-11.
30. Nguyen HB, Klein W, Corbett SW, et al. Early goal-directed therapy, corticosteroids and activated protein C for severe sepsis/septic shock in the emergency department. Presented at the 34th Congress of the Society of Critical Care Medicine, 15-19 January 2005, Phoenix, AZ.
31. Laterre P-F, Levy H, Ball D, et al. The effect of drotrecogin alpha (activated) on hospital mortality, length of stay and discharge location. Chest 2002;122(suppl):S143.
32. Cabana MD, Rand CS, Powe NR, et al. Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA 1999;282:1458-65.